Evidence map›Paper›PMID 42719583›Full record

ArticleJournal of neuroendovascular therapy2026

Transvenous Embolization for Complex Anterior Cranial Fossa Dural Arteriovenous Fistula Following Prior Embolization: A Case Report.

Akihiro Shimoi, Keisuke Yoshida, Kazunori Akaji, Tomoaki Terada

Abstract readCase Reports
In one paragraph

Article in Journal of neuroendovascular therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Akihiro ShimoiDepartment of Neurosurgery, Mihara Memorial Hospital, Isesaki, Gunma, Japan.
Keisuke YoshidaDepartment of Neurosurgery, Mihara Memorial Hospital, Isesaki, Gunma, Japan.
Kazunori AkajiDepartment of Neurosurgery, Mihara Memorial Hospital, Isesaki, Gunma, Japan.
Tomoaki TeradaDepartment of Neurosurgery, Showa Medical University Northern Yokohama Hospital, Yokohama, Kanagawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Anterior cranial fossa dural arteriovenous fistulas (ACF DAVFs) are high-risk lesions because of cortical venous drainage and are generally treated by surgical interruption of the draining vein or transarterial embolization (TAE). Transvenous embolization (TVE) has recently emerged as an alternative treatment in selected cases. Case Presentation: A 67-year-old man with a residual ACF DAVF after previous bilateral ophthalmic artery Onyx (Medtronic, Irvine, CA, USA) embolization was referred for additional treatment. Repeat TAE was considered anatomically difficult because of distal ophthalmic artery occlusion after prior treatment. Craniotomy was presented as the standard treatment but was declined by the patient. Preoperative imaging demonstrated focal shunt localization and feasible venous access to the foot of the draining vein. TVE was therefore performed using selective venous catheterization and Onyx embolization. Complete angiographic obliteration was achieved without neurological deficit, hemorrhagic complication, or postoperative olfactory disturbance. Because of strong resistance during catheter retrieval, the microcatheter was intentionally retained to avoid venous injury. Conclusion: TVE may represent a feasible alternative for selected residual ACF DAVFs after prior embolization when additional arterial access is limited and the venous anatomy is favorable. Careful patient selection and meticulous procedural planning remain essential.

Indexed as

anterior cranial fossa dural arteriovenous fistulaOnyx embolizationtransarterial embolizationtransvenous embolization

Identifiers

PMID42719583
PMCPMC13555328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.